NDC 50480-052 - CMPK2
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50480-052
- Package NDCs from labels
- 50480-052-50
- Manufacturer
- Radix Laboratories, Inc.
- Effective date
- 2014-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CMPK2 | Radix Laboratories, Inc. | 2014-03-24 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50480-052-50 | CMPK2 | 12 in 1 CARTON | LIQUID | 12 | 3 | |
| 50480-052-50 | CMPK2 | 500 mL in 1 BOTTLE, PLASTIC | LIQUID | 500 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CALCIUM BOROGLUCONATE | ACTIVE INGREDIENT | 6915G2PQI0 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LX22YL083G | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| MAGNESIUM CHLORIDE | ACTIVE INGREDIENT | 02F3473H9O | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| SODIUM HYPOPHOSPHITE | ACTIVE INGREDIENT | 8TU1537O43 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| HYPOPHOSPHITE ION | ACTIVE MOIETY | 238U65NZ04 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Bryant Ranch Prepack | b5505a39-57f1-4ed5-b845-4f1d8aa10950 | 2024-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 3c5f0f65-8a54-4a55-ad4e-0f0be97631d7 | 2024-09-15 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 863e6980-4a66-48a5-a14f-828a00480c93 | 2024-08-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | American Health Packaging | 8c12c5f8-5950-44e3-9473-a0b95187b43c | 2024-08-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | LX22YL083G |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Epic Pharma, LLC | 1373321f-533a-4ab4-8bcd-8bde15371a09 | 2024-08-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 7427c29e-55c1-4c30-b091-058c8bec592f | 2024-08-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | f1791d4f-029a-487f-aee1-fc5be246d0bc | 2024-08-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 80dd5de2-5066-472b-b1f8-88070a5c7388 | 2024-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Drainage | ECHINACEA (ANGUSTIFOLIA), TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, CALCAREA IODATA, KALI MURIATICUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, SULPHUR IODATUM | BioActive Nutritional, Inc. | 7920e8f6-be48-4402-9085-9673779db5a2 | 2024-07-31 | Warnings | 660YQ98I10 |
| Pineal Liquescence | VALERIANA OFFICINALIS, HYDROCOTYLE ASIATICA, MELATONIN, CEREBRUM SUIS, HYPOTHALAMUS SUIS, PINEAL GLAND (SUIS), SCUTELLARIA LATERIFLORA, STELLARIA MEDIA, CALCAREA CARBONICA, ZINCUM METALLICUM, AURUM METALLICUM, DOPAMINE (HYDROCHLORIDE), SEROTONIN (HYDROCHLORIDE), MAGNESIA MURIATICA | Nutritional Specialties, Inc. | ccaf3166-5e2f-4c7f-80a8-ee722bdf0c5b | 2024-07-24 | Warnings | 02F3473H9O |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | 3849b89c-c309-46fb-a1e2-53ff0c65077f | 2024-07-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Bryant Ranch Prepack | 7b8e7a4f-0d44-46b2-9565-7b4c294e9fcb | 2024-07-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | b5a6b6f2-d073-4bd3-a66c-bf34ccabfe51 | 2024-07-18 | Warnings, Adverse reactions | 660YQ98I10 |
| WINTER BLEND | ECHINACEA (ANGUSTIFOLIA), UVA-URSI, BAPTISIA TINCTORIA, CONVALLARIA MAJALIS, KALI MURIATICUM, PINUS SYLVESTRIS, THUJA OCCIDENTALIS, BRYONIA, CROTALUS HORRIDUS, LACHESIS MUTUS, SELENIUM METALLICUM, VISCUM ALBUM | Energique, Inc. | ff696389-bad5-463a-be99-e92e86250e86 | 2024-07-12 | Warnings | 660YQ98I10 |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | 02F3473H9O 660YQ98I10 LX22YL083G |
| KALI MUR | KALI MUR | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | 1a3522bc-3d43-ea96-e063-6394a90aa2cc | 2024-06-06 | Warnings | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Proficient Rx LP | c53d1db5-1c9e-4289-a2a2-961e0dd56f32 | 2024-06-01 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.